About this trial
This study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children across US pediatric health systems. The first part of the study is to form a multidisciplinary team of stakeholders, including parents, providers, nurses, pharmacists, informaticists, data analysts and communication experts across three sites in synthesizing a best practice implementation guide for an inpatient influenza vaccination program, which will then be piloted at these three sites.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
At least 6 months of age
Admitted to an inpatient unit at a participating health system
Disqualifiers
At least 6 months of age
Admitted to an inpatient unit at a participating health system
Trial design
Sequential
Treatments tested in this trial
Existing Influenza Vaccination Practices
Other interventionUsual care is defined as the existing inpatient influenza vaccination practices that currently exist at a given site.
Standardized inpatient influenza vaccination program
Other interventionIntervention A: The basic intervention is the inpatient influenza vaccination program Intervention B: The intensified intervention is the multifaceted influenza vaccination strategy (Intervention A) plus a learning collaborative
Treatment groups
Trial outcomes
Primary outcomes
Vaccine administration rate
proportion of influenza vaccine administrations to eligible patients during hospitalization.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Colorado, Denver
Lead sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator
Seattle Children's Hospital
Collaborator